Journal Article Summary
The article investigates the emergence of resistance to clotrimazole, an antifungal medication, in children with HIV who are prone to oropharyngeal candidiasis (OPC). This topic is significant because OPC is a common infection in immunocompromised individuals, and understanding resistance patterns can help inform treatment strategies. Clotrimazole is frequently used to manage mucosal candidiasis, but the potential for resistance could lead to treatment failures, making it crucial to explore this issue in a vulnerable population.
The study involved 87 HIV-infected children, where researchers tested the effectiveness of clotrimazole against samples of Candida albicans, the fungus responsible for OPC. They used two methods to determine the minimum inhibitory concentration (MIC) of clotrimazole, which indicates how much of the drug is needed to prevent fungal growth. The results showed that while most isolates had low MICs, a significant number of patients with higher MICs (≥0.5 μg/ml) experienced treatment failures and required alternative therapies like amphotericin B. This highlights a concerning link between resistance levels and the effectiveness of standard antifungal treatments.
Limitations of the study include its focus on a specific population, which may not represent all HIV-infected individuals, and the potential for variability in clinical responses. Patients and caregivers should be aware of the risk of antifungal resistance and discuss any concerns about treatment effectiveness with healthcare professionals. It is essential to monitor symptoms and treatment responses closely, as changes in medication may be necessary if resistance is suspected.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Pelletier René, Peter Joanne, Antin Cynthia, Gonzalez Corina, Wood Lauren, Walsh Thomas J.. Emergence of Resistance of Candida albicans to Clotrimazole in Human Immunodeficiency Virus-Infected Children: In Vitro and Clinical Correlations. Journal of Clinical Microbiology 2000. DOI: 10.1128/jcm.38.4.1563-1568.2000. PMID: 10747144. PMCID: PMC86490.
Featured Pill Pals Product
Clotrimazole 1 Percent (1%) Cream 28g (1 oz) --- Generic for Lotrimin AF Pack of 5 --- Major / Rugby
Clotrimazole 1 Percent (1%) Cream 28g (1 oz) --- Generic for Lotrimin AF Pack of 5 --- Major / Rugby is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
